9 chemical powerhouses

Summary: As India’s chemical sector emerges from a two-year slump, demand is reviving and global supply chains are shifting. But the winners this time won’t be commodity players—they’ll be firms betting big on specialty niches and import substitution. This deep dive identifies nine such companies building defensible moats in a high-potential but risky landscape. Take any strategy game. Whether it’s Civilization, StarCraft or even Risk, the early moves decide the endgame. Players who rush to expand indiscriminately soon collapse. Those who secure critical resources and build defensible positions patiently dominate when the real battles begin. India’s chemical sector is entering such a moment. After a bruising two-year downturn, demand is reviving, prices are stabilising and supply chains are shifting decisively away from China. The board is resetting and the next campaign could be a long one. But victory won’t be evenly shared. While commoditised players are still slugging it out in endless price wars, those using strategy and building fortresses, companies carving out high-margin specialty niches or investing in import-dependent products where demand is locked in for years, will emerge as winners. This story is your strategic map. We’ll show you why chemicals deserve a place on your radar again, trace how the industry got to where it is today and point to the segments and specific players that could be the next decade’s biggest wealth creators. Why look at chemicals at all? First, let’s address the obvious question: why even bother with chemicals after two years of pain? That’s because the revival is not just a dead cat bounce. It’s a structural reset in the making. Chemicals aren’t a cyclical bolt-on to the economy; they are its backbone. From pharmaceuticals and textiles to food processing, paints, packaging and electronics, the industry touches almost every manufactured good we consume. And now with China’s grip on global chemical manufacturing loosening, as rising labour costs and geopolitical frictions with the West make global buyers wary of depending too heavily on a single geography, India is emerging as the natural alternative. This shift opens up a runway of staggering proportions. EY pegs India’s chemical industry at $383 billion by 2030, potentially tripling to $1 trillion by 2040. That implies a near-9 per cent growth runway for years to come, a scale that few other Indian industries can match. That’s the macro case. But to understand why investors should pay attention now, we need to revisit the industry’s recent boom-bust cycle. Where we are now: An inflection point Much of the recent slump was not due to a collapse in end-user demand but an inventory overhang. That excess stock has now been worked down. Orders are trickling back, prices stabilising and supply balancing out. FY25 has thus been better with revenue growth of 5 per cent and profit growth of 28 per cent. Not every sub-segment has recovered but the direction is positive and this could well be an inflection point. What helps is that companies did not slam brakes on investment during the downturn. Over the last three years, the industry sustained capital expenditure at 5.8 per cent of revenue, above the long-term average of 5.5 per cent. According to McKinsey, Indian chemical firms have lined up around $11 billion in fresh capex over the next three years, not counting large government-led petrochemical projects. And this is not just capacity for bulk chemicals. The planned investments also span specialty and import substitution bets that could pay off disproportionately. Where the next leg lies: Specialty and import-dependent niches A decade ago, success simply came from throwing up capacity when China was cutting back. That won’t fly anymore. China is back online in commoditised bulk chemicals. Competing head-on will be a race to the bottom. This is why specialty chemicals—high-margin, niche segments where switching costs are high, and import substitution—products where India’s $15-billion annual chemical trade deficit promises steady domestic demand—are the next opportunities to keep an eye on. Specialty chemicals are not a new theme but their relevance has grown. These players supply small but critical molecules that feed into pharma, agrochemicals, textiles, etc. Their contracts are sticky, pricing power is stronger with lower risks of oversupply. Import substitution, meanwhile, is the rising star. India remains heavily dependent on imported intermediates, many from China. Companies that build domestic capacity here get to tap a ready market and even achieve leadership. Take Deepak Nitrite as an example. India used to import almost all its phenol. Deepak began to invest in local capacity in 2017 to meet this demand. Today, phenol and derivatives make up 70 per cent of its revenues. One strategic capex cycle created a defensible moat. That’s the template. By contrast, commodity players, those making mass volumes of basic chemicals, are exposed to brutal pricing swings and risk of supply glut. Their margins rise and fall with Chinese supply cycles. The sector’s comeback will not lift all boats. For investors, this distinction is critical. Tariffs and other risks in the mix For all the sunshine in India’s chemical story, there are shadows that investors must reckon with. Chief among them: tariffs. The US has imposed a 10 per cent baseline levy on chemicals alongside a reciprocal tariff of 26 per cent on non-pharma goods. For an industry that exported chemicals worth nearly $20 billion in FY24, of which the US absorbed about $3 billion, this is no small irritant. And the effect is rarely confined to direct exports. Even a chemical maker that serves only domestic clients may find itself caught in the crossfire. Take textiles exporters that now face a punitive 50 per cent tariff into the US. A squeeze on textile demand trickles back to their chemical suppliers, choking orders. In such a tightly woven web of supply chains, indirect exposure can be as damaging as direct. India’s relative

This article was originally published on September 01, 2025.